In June 2024, Clinical Laserthermia Systems AB (publ) (“CLS” or the “Company”) carried out a rights issue of shares and warrants of series TO 7 B (the “Rights Issue”). The exercise period for the warrants begins today, November 11, 2024 and runs up to and including November 22, 2024. One (1) …
